COVID-19 vaccine: where are we now and where should we go?
S Soleimanpour, A Yaghoubi - Expert review of vaccines, 2021 - Taylor & Francis
Introduction The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has
currently caused the pandemic with a high progressive speed and has been considered as …
currently caused the pandemic with a high progressive speed and has been considered as …
A COVID-19 vaccine: big strides come with big challenges
J Mellet, MS Pepper - Vaccines, 2021 - mdpi.com
As of 8 January 2021, there were 86,749,940 confirmed coronavirus disease 2019 (COVID-
19) cases and 1,890,342 COVID-19-related deaths worldwide, as reported by the World …
19) cases and 1,890,342 COVID-19-related deaths worldwide, as reported by the World …
A Review of the Progress and Challenges of Developing a Vaccine for COVID-19
A novel coronavirus, which has been designated as severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), was first detected in December 2019 in Wuhan China and …
coronavirus 2 (SARS-CoV-2), was first detected in December 2019 in Wuhan China and …
The COVID-19 vaccines: recent development, challenges and prospects
Y Yan, Y Pang, Z Lyu, R Wang, X Wu, C You, H Zhao… - Vaccines, 2021 - mdpi.com
The highly infectious coronavirus disease 2019 (COVID-19) associated with the pathogenic
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread to become a …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread to become a …
A systematic review on COVID-19 vaccine strategies, their effectiveness, and issues
SS Khandker, B Godman, MI Jawad, BA Meghla… - Vaccines, 2021 - mdpi.com
COVID-19 vaccines are indispensable, with the number of cases and mortality still rising,
and currently no medicines are routinely available for reducing morbidity and mortality, apart …
and currently no medicines are routinely available for reducing morbidity and mortality, apart …
COVID-19 Vaccines over Three Years after the Outbreak of the COVID-19 Epidemic
AA Zasada, A Darlińska, A Wiatrzyk, K Woźnica… - Viruses, 2023 - mdpi.com
The outbreak of COVID-19 started in December 2019 and spread rapidly all over the world.
It became clear that the development of an effective vaccine was the only way to stop the …
It became clear that the development of an effective vaccine was the only way to stop the …
COVID-19: coronavirus vaccine development updates
J Zhao, S Zhao, J Ou, J Zhang, W Lan, W Guan… - Frontiers in …, 2020 - frontiersin.org
Coronavirus Disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2), a newly emerged coronavirus, and has been pandemic since …
Coronavirus 2 (SARS-CoV-2), a newly emerged coronavirus, and has been pandemic since …
COVID-19: Insights into potential vaccines
People around the world ushered in the new year 2021 with a fear of COVID-19, as family
members have lost their loved ones to the disease. Millions of people have been infected …
members have lost their loved ones to the disease. Millions of people have been infected …
[HTML][HTML] A review on the advancements in the development of vaccines to combat coronavirus disease 2019
H Onyeaka, ZT Al-Sharify, MY Ghadhban… - Clinical and …, 2021 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19), the deadly disease caused by SARS-CoV-
2 (severe acute respiratory syndrome coronavirus 2) is a global pandemic that has severely …
2 (severe acute respiratory syndrome coronavirus 2) is a global pandemic that has severely …
[HTML][HTML] COVID-19 vaccines
D Ndwandwe, CS Wiysonge - Current opinion in immunology, 2021 - Elsevier
Highlights•COVID-19 vaccine development has accelerated at an incredible rate with 105
vaccines in clinical development and 18 approved for emergency use.•This is the first time in …
vaccines in clinical development and 18 approved for emergency use.•This is the first time in …